Patel Nikunj K, Plaha Puneet, Gill Steven S
Institute of Neurosciences, Frenchay Hospital, Bristol, England.
Neurosurgery. 2007 Nov;61(5 Suppl 2):358-65; discussion 365-6. doi: 10.1227/01.neu.0000303994.89773.01.
We present a magnetic resonance imaging-directed stereotactic system using implantable guide tubes for targeting deep brain nuclei in functional neurosurgery.
Our method relies on visualization of the deep brain nuclei on high-resolution magnetic resonance images that delineate the target boundaries and enable direct targeting of specific regions of the nucleus. The delivery system comprises a modified stereoguide capable of delivering an implantable guide tube to the vicinity of the desired target. The guide tube (in-house investigational device) has a hub at its proximal end that is fixed within a burr hole and accommodates a radioopaque stylette that is inserted such that its distal end is at the desired target. After perioperative radiological confirmation of the stylette's relationship to the desired brain target, it is withdrawn from the guide tube, which may then act as a port for the implantation of an electrode for deep brain stimulation (DBS) or radiofrequency lesioning. Alternatively, the guide tube can be used to insert a catheter for drug delivery, cell transplantation, or viral-vector delivery. Implantation and verification are guided by magnetic resonance imaging or computed tomography, which enable the entire procedure to be performed under general anesthesia. The technique of implantation helps ensure optimal accuracy, and we have successfully used this device for implanting electrodes for DBS in the treatment of Parkinson's disease, essential tremor, and dystonia, and for implanting catheters for continuous delivery of glial-derived neurotrophic factor in the treatment of Parkinson's disease. The device also aids in securely fixing the DBS electrode or catheter to the cranium with ease, limiting hardware problems.
A total of 205 guide tubes have been implanted in 101 patients. Major complications in these cases were limited to 4% of patients. At the initial implantations, 96.3% of the guide tubes were within 1.5 mm of the target. Ten guide tubes required reimplantation secondary to target errors. With corrections, the DBS electrode was delivered to within 1.5 mm from the planned target in all cases.
This system provides a safe and accurate magnetic resonance imaging-directed system for targeting deep brain nuclei in functional neurosurgery under general anesthesia and avoids the need for electrophysiological monitoring.
我们展示一种磁共振成像引导的立体定向系统,该系统使用可植入导向管来靶向功能神经外科中的深部脑核。
我们的方法依赖于在高分辨率磁共振图像上对深部脑核进行可视化,这些图像描绘了目标边界并能够直接靶向核的特定区域。输送系统包括一个改良的立体定向导向器,能够将可植入导向管输送到所需目标附近。导向管(内部研究设备)在其近端有一个毂,该毂固定在骨孔内,并容纳一个不透射线的探针,插入该探针使得其远端位于所需目标处。在围手术期通过放射学确认探针与所需脑目标的关系后,将其从导向管中取出,然后导向管可作为植入深部脑刺激(DBS)电极或进行射频毁损的端口。或者,导向管可用于插入用于药物递送、细胞移植或病毒载体递送的导管。植入和验证由磁共振成像或计算机断层扫描引导,这使得整个过程能够在全身麻醉下进行。植入技术有助于确保最佳准确性,并且我们已成功使用该设备植入用于治疗帕金森病、特发性震颤和肌张力障碍的DBS电极,以及用于治疗帕金森病的持续递送胶质细胞源性神经营养因子的导管。该设备还有助于轻松地将DBS电极或导管牢固地固定在颅骨上,减少硬件问题。
共对101例患者植入了205根导向管。这些病例中的主要并发症仅限于4%的患者。在初次植入时,96.3%的导向管位于目标的1.5毫米范围内。10根导向管因目标误差需要重新植入。经过校正后,所有病例中DBS电极都被输送到距离计划目标1.5毫米以内。
该系统为全身麻醉下功能神经外科中靶向深部脑核提供了一种安全、准确的磁共振成像引导系统,并且无需电生理监测。